The anti-apoptotic activity associated with phosphatidylinositol transfer protein alpha activates the MAPK and

Martijn Schenning1, Joachim Goedhart, Theodorus W J Gadella

  • 1Bijvoet Center, Department of Biochemistry of Lipids, Institute of Biomembranes, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands. M.Schenning@Dundee.ac.uk

Insights

Overexpressing phosphatidylinositol transfer protein alpha (PI-TPalpha) in mouse fibroblasts increases anti-apoptotic activity via a cannabinoid 1 (CB1)-like receptor. This activation triggers ERK/MAP kinase and Akt/PKB pathways, enhancing cell survival.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Phosphatidylinositol transfer protein alpha (PI-TPalpha) overexpression in NIH3T3 fibroblasts enhances anti-apoptotic activity.
  • This activity is mediated by a G protein-coupled receptor, likely a cannabinoid 1 (CB1)-like receptor, as indicated by pertussis toxin and rimonabant sensitivity.
  • CB1 receptor expression levels vary among NIH3T3 cell lines: SPIalpha > wtNIH3T3 > SPIbeta.

Purpose of the Study:

  • To elucidate the downstream signaling pathways activated by PI-TPalpha-dependent anti-apoptotic factors.
  • To investigate the role of the CB1-like receptor in mediating these downstream effects.
  • To determine if phospholipase C (PLC) activation is involved in the observed anti-apoptotic signaling.

Main Methods:

  • Western blotting to detect activation of ERK/MAP kinase and Akt/PKB pathways.
  • Confocal laser scanning microscopy to visualize EYFP-ERK2 nuclear translocation.
  • Analysis of YFP-labelled C2-domain of protein kinase C translocation to the plasma membrane.

Main Results:

  • Incubation of SPIbeta cells with PI-TPalpha-dependent factors activated ERK/MAP kinase and Akt/PKB pathways in a CB1 receptor-dependent manner.
  • EYFP-ERK2 translocation to the nucleus confirmed ERK2 activation.
  • Activation of the anti-apoptotic transcription factor NF-kappaB was observed, correlating with increased resistance to UV-induced apoptosis.
  • No evidence of phospholipase C activation was found, as indicated by the lack of YFP-labelled C2-domain translocation.

Conclusions:

  • PI-TPalpha-mediated anti-apoptotic activity in NIH3T3 cells involves the activation of ERK/MAP kinase and Akt/PKB signaling pathways through a CB1-like receptor.
  • This signaling cascade leads to the activation of NF-kappaB and enhanced resistance to apoptosis.
  • The anti-apoptotic effect does not appear to involve phospholipase C activation.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...